Abbott Laboratories Pre-Tax Income 2010-2024 | ABT

Abbott Laboratories annual/quarterly pre-tax income history and growth rate from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
  • Abbott Laboratories pre-tax income for the quarter ending December 31, 2024 was $2.030B, a 13.09% increase year-over-year.
  • Abbott Laboratories pre-tax income for the twelve months ending December 31, 2024 was $7.013B, a 5.24% increase year-over-year.
  • Abbott Laboratories annual pre-tax income for 2024 was $7.013B, a 5.24% increase from 2023.
  • Abbott Laboratories annual pre-tax income for 2023 was $6.664B, a 19.77% decline from 2022.
  • Abbott Laboratories annual pre-tax income for 2022 was $8.306B, a 1.16% increase from 2021.
Abbott Laboratories Annual Pre-Tax Income
(Millions of US $)
2024 $7,013
2023 $6,664
2022 $8,306
2021 $8,211
2020 $4,968
2019 $4,077
2018 $2,873
2017 $2,231
2016 $1,413
2015 $3,183
2014 $2,518
2013 $2,041
2012 $-220
2011 $1,236
2010 $5,713
2009 $7,194
Abbott Laboratories Quarterly Pre-Tax Income
(Millions of US $)
2024-12-31 $2,030
2024-09-30 $1,940
2024-06-30 $1,607
2024-03-31 $1,436
2023-12-31 $1,795
2023-09-30 $1,671
2023-06-30 $1,636
2023-03-31 $1,562
2022-12-31 $1,320
2022-09-30 $1,758
2022-06-30 $2,352
2022-03-31 $2,876
2021-12-31 $2,327
2021-09-30 $2,493
2021-06-30 $1,348
2021-03-31 $2,043
2020-12-31 $2,388
2020-09-30 $1,421
2020-06-30 $526
2020-03-31 $633
2019-12-31 $1,240
2019-09-30 $1,103
2019-06-30 $1,102
2019-03-31 $632
2018-12-31 $947
2018-09-30 $718
2018-06-30 $777
2018-03-31 $431
2017-12-31 $574
2017-09-30 $626
2017-06-30 $295
2017-03-31 $736
2016-12-31 $875
2016-09-30 $-179
2016-06-30 $715
2016-03-31 $2
2015-12-31 $830
2015-09-30 $714
2015-06-30 $986
2015-03-31 $653
2014-12-31 $804
2014-09-30 $715
2014-06-30 $658
2014-03-31 $341
2013-12-31 $405
2013-09-30 $481
2013-06-30 $601
2013-03-31 $554
2012-12-31 $-1,444
2012-09-30 $231
2012-06-30 $530
2012-03-31 $463
2011-12-31 $1,954
2011-09-30 $502
2011-06-30 $1,675
2011-03-31 $1,069
2010-12-31 $1,768
2010-09-30 $1,064
2010-06-30 $1,559
2010-03-31 $1,322
2009-12-31 $1,823
2009-09-30 $1,871
2009-06-30 $1,567
2009-03-31 $1,932
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $222.392B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $154.781B 41.84
Stryker (SYK) United States $150.988B 32.49
EssilorLuxottica (ESLOY) France $128.761B 0.00
Medtronic (MDT) Ireland $116.457B 17.30
Lonza Group Ag (LZAGY) Switzerland $48.724B 0.00
Haleon (HLN) United Kingdom $43.049B 27.97
Agilent Technologies (A) United States $42.120B 27.91
GE HealthCare Technologies (GEHC) United States $40.456B 20.98
ResMed (RMD) United States $34.834B 26.83
Terumo (TRUMY) Japan $27.701B 39.39
Koninklijke Philips (PHG) Netherlands $25.801B 19.75
Zimmer Biomet Holdings (ZBH) United States $20.443B 12.84
Insulet (PODD) United States $20.179B 80.36
Baxter (BAX) United States $15.731B 10.24
Smith & Nephew SNATS (SNN) United Kingdom $11.039B 0.00
Sunny Optical Technology (SNPTF) China $9.976B 0.00
BellRing Brands (BRBR) United States $9.951B 37.15
Bio-Rad Laboratories (BIO) United States $9.670B 32.87
Demant (WILYY) Denmark $7.946B 0.00
Lantheus Holdings (LNTH) United States $6.320B 14.69
Prestige Consumer Healthcare (PBH) United States $4.316B 20.65
ICU Medical (ICUI) United States $3.878B 36.92
Envista Holdings (NVST) United States $3.750B 29.85
Perrigo (PRGO) Ireland $3.407B 10.03
Haemonetics (HAE) United States $3.164B 14.89
GN Store Nord (GNNDY) Denmark $3.123B 21.05
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
QuidelOrtho (QDEL) United States $2.832B 18.23
Neogen (NEOG) United States $2.315B 26.67
LeMaitre Vascular (LMAT) United States $2.245B 54.55
AtriCure (ATRC) United States $1.997B 0.00
Green Thumb Industries (GTBIF) United States $1.513B 26.48
AdaptHealth (AHCO) United States $1.300B 9.29
InMode (INMD) Israel $1.269B 10.61
Maravai LifeSciences Holdings (MRVI) United States $1.250B 0.00
BioLife Solutions (BLFS) United States $1.215B 0.00
Curaleaf Holdings (CURLF) Canada $1.069B 0.00
Phibro Animal Health (PAHC) United States $0.996B 15.27
Evolus (EOLS) United States $0.849B 0.00
CeriBell (CBLL) United States $0.810B 0.00
Owens & Minor (OMI) United States $0.667B 5.21
Capricor Therapeutics (CAPR) United States $0.652B 0.00
VAREX IMAGING (VREX) United States $0.627B 27.14
Valneva SE (VALN) France $0.563B 0.00
Omeros (OMER) United States $0.526B 0.00
SNDL (SNDL) Canada $0.507B 0.00
Surmodics (SRDX) United States $0.487B 0.00
Cresco Labs (CRLBF) United States $0.474B 0.00
Verano Holdings (VRNOF) United States $0.424B 0.00
ZimVie (ZIMV) United States $0.383B 32.26
Canopy Growth (CGC) Canada $0.363B 0.00
Aurora Cannabis (ACB) Canada $0.343B 62.50
Cerus (CERS) United States $0.323B 0.00
Quanterix (QTRX) United States $0.320B 0.00
Viemed Healthcare (VMD) United States $0.317B 30.11
Sanara MedTech (SMTI) United States $0.309B 0.00
OraSure Technologies (OSUR) United States $0.292B 19.55
Biote (BTMD) United States $0.261B 5.73
Zynex (ZYXI) United States $0.252B 52.80
High Tide (HITI) Canada $0.238B 0.00
Sanuwave Health (SNWV) United States $0.232B 3.26
SEMPERIT AG HLD (SEIGY) Austria $0.226B 0.00
Organigram Holdings (OGI) Canada $0.209B 0.00
TerrAscend (TSNDF) Canada $0.209B 0.00
Utah Medical Products (UTMD) United States $0.203B 15.16
Brainsway (BWAY) Israel $0.200B 106.40
MacroGenics (MGNX) United States $0.174B 0.00
TriSalus Life Sciences (TLSI) United States $0.164B 0.00
FitLife Brands (FTLF) United States $0.142B 17.83
Jin Medical (ZJYL) China $0.130B 0.00
Quipt Home Medical (QIPT) United States $0.127B 0.00
Fonar (FONR) United States $0.101B 11.44
Exagen (XGN) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Veru (VERU) United States $0.085B 0.00
InterCure (INCR) Israel $0.080B 0.00
Jushi Holdings (JUSHF) United States $0.073B 0.00
INLIF (INLF) $0.067B 0.00
Rockwell Medical (RMTI) United States $0.064B 33.00
Cytosorbents (CTSO) United States $0.057B 0.00
Ayr Wellness (AYRWF) United States $0.055B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
MariMed (MRMD) United States $0.051B 0.00
United-Guardian (UG) United States $0.051B 14.60
Modular Medical (MODD) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Nephros (NEPH) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00